1 The Discovery and Development of Atorvastatin, A Potent Novel Hypolipidemic Agent

Progress in Medicinal Chemistry

Volumn 40, Issue C, 2002, Pages 1-22

  Roth, Bruce D ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; PYRROLE DERIVATIVE;

ANIMAL; CHEMISTRY; HUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTICHOLESTEREMIC AGENTS; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PYRROLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036986060     PISSN: 00796468     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6468(08)70080-8     Document Type: Article

References (53)

1. Bloch K. Science 150 692 (1965) 19-28
2. Goldstein J.L., and Brown M.S. J. Lipid Res. 25 (1984) 1450-1461
3. Blohm T.R., and MacKenzie R.D. Arch. Biochem. Biophys. 85 (1959) 245
4. Avigan J., Steinberg D., Vroman H.E., Thompson M.J., and Mosettig E. J. Biol. Chem 235 (1960) 3123-3126
5. Laughlin R.C., and Carey T.F. J. Amer. Med. Assoc. 181 (1962) 339-340
6. Curran G.L., and Azarnoff D.L. Arch. Internal Med. 101 (1958) 685-689
7. Steinberg D., and Avigan J. J. Biol. Chem. 235 (1960) 3127-3129
8. Avigan J., Steinberg D., Thompson M.J., and Mossettig E. Biochem. Biophys. Res. Commun. 2 (1960) 63-65
9. Davey-Smith G., and Pekkanen J. BMJ 304 (1992) 431-434
10. Scandinavian Simvastatin Survival Study Group. Lancet 344 (1994) 1383-1389
11. Boots M.R., Boots S.G., Noble C.M., and Guyer K.E. J. Pharm. Sci. 62 (1973) 952
12. Rogers D.H., Panini S.R., and Rudney H. In: Sabine J.R. (Ed). S-Hydroxy-3-methylglutaryl Coenzyme A Reductase (1983), CRC Press, Boca Raton, FL 66 Chapter 6
13. Brown A.G., Smale T.C., King T.J., Hasenkamp R., and Thompson R.H. J. Chem. Soc. Perkin I (1976) 1165-1170
14. Endo A., Tsujita Y., Kuroda M., and Tanzawa K. Eur. J. Biochem. 77 (1977) 31-36
15. Tsujita Y., Kuroda M., Tanzawa K., Kitano N., and Endo A. Atherosclerosis 32 (1979) 307-313
16. Kuroda M., Tsujita Y., Tanzawa K., and Endo A. Lipids 14 (1979) 589-858
17. Mabuehi H., Haba T., Tatami R., Miyamoto S., Sakai Y., Wakasugi T., Watanabe A., Koizumi J., and Takeda R. N. Engl. J. Med. 305 (1981) 478-482
18. Alberts A.W., Chen J., Kuron G., Hunt V., Huff J., Hoffman C., Rothrock J., Lopez M., Joshua H., Harris E., Patchett A., Monaghan R., Currie S., Stapley E., Albers-Schonberg G., Hensens O., Hirshfield J., Hoogsteen K., Liesch J., and Springer J. Proc. Nat. Acad. Sci. USA 77 (1980) 3957-3961
19. Endo A. J. Antibiotics 32 (1979) 852-854
20. Serizawa N., Nakagawa K., Hamano K., Tsujita Y., Terahara A., and Kuwano H. J. Antibiotics 36 (1983) 604-607
21. Hoffman W.F., Alberts A.W., Anderson P.S., Chen J.S., Smith R.L., and Willard A.K. J. Med. Chem. 29 (1986) 849-852
22. Endo A. Klin. Wochenschr. 66 (1988) 421-427
23. Willard, A. K., Novello, F. C., Hoffmann, W. F., Cragoe, E. J. Jr. USP 4459422.
24. Stokker G.E., Alberts A.W., Anderson P.S., Cragoe Jr. E.J., Deana A.A., Gilfillan J.L., Hirshfield J., Holtz W.J., Hoffman W.F., et al. J. Med. Chem. 29 (1986) 170-181
25. Roth B.D., Ortwine D.F., Hoefle M.L., Stratton C.D., Sliskovic D.R., Wilson M.W., and Newton R.S. J. Med. Chem. 33 (1990) 21-31
26. Kathawala F.G. Trends in Medicinal Chemistry 88 (1989) 709-728
27. Knorr L. Ber. 18 (1885) 299
28. Paal C. Ber. 18 (1885) 367
29. Stetter H. Angew. Chem., Int. Ed. Eng. 15 (1976) 639
30. Huckin S.N., and Weiler L. J. Am. Chem. Soc. 103 (1981) 6538-6539
31. Narasaka K., and Pai H.C. Chem. Lett. (1980) 1415-1418
32. Roth B.D., Blankley C.J., Chucholowski A.W., Ferguson E., Hoefle M.L., Ortwine D.F., Newton R.S., Sekerke C.S., Sliskovic D.R., Stratton C.D., and Wilson M.W. J. Med. Chem. 34 (1991) 357-366
33. Sigler R.E., Dominick M.A., and McGuire E.J. Toxicol. Pathol. 20 (1992) 595-602
34. MacDonald J.S., Gerson R.J., Kornbrust D.J., Kloss M.W., Prahalada S., Berry P.H., Alberts A.W., and Bokelman D.L. Am. J. Cardiol. 62 (1988) 16J-27J
35. Gerson R.J., Allen H.L., Lankas G.R., MacDonald J.S., Alberts A.W., and Bokelman D.L. Fundam. Appl. Toxicol. 16 (1988) 320-329
36. Sliskovic D.R., Roth B.D., Wilson M.W., Hoefle M.L., and Newton R.S. Med. Chem. 33 (1990) 31-38
37. Sliskovic D.R., Picard J.A., Roark W.H., Roth B.D., Krause B.R., Newton R.S., Sekerke C., and Shaw M.K. J. Med. Chem. 34 (1991) 367-373
38. Newton D.M., and Ramsden C.A. Tetrahedron 38 (1982) 2965-3011
39. Auerbach B.J., Krause B.R., Bisgaier C.L., and Newton R.S. Atherosclerosis (Shannon, Irel.) 115 (1995) 173-180
40. Krause B.R., and Newton R.S. Atherosclerosis (Shannon. Irel.) 117 (1995) 237-244
41. Braun M., and Devant R. Tetrahedron Lett. (1984) 5031-5034
42. Browner P.L., Butler D.E., Deering C.F., Le T.V., Millar A., Nanninga T.N., and Roth B.D. Tetrahedron Lett. (1992) 2279-2282
43. Baumann K.L., Butler D.E., Deering C.F., Mennen K.E., Millar A., Nanninga T.N., Palmer C.W., and Roth B.D. Tetrahedron Lett. (1992) 2283-2284
44. Sletzinger M., Verhoeven T.R., McNamara J.M., Corley E.G., and Lui T.M.H. Tetrahedron Lett. (1985) 2951-2955
45. Isbell H.S., and Frush H.L. Carhohyd. Res. 72 (1979) 301-304
46. Bock K., Lundt I., and Pedersen C. Acta Chem. Scand. 37B (1983) 341-344
47. Brooks D.W., Lu L., and Masamune D.-L.S. Angew. Chem. Int. Ed. Eng. 18 (1979) 72
48. Chen K.M., Hardtmami G.E., Prasad K., Repic O., and Shapiro M.J. Tetrahedron Lett. (1987) 155-159
49. Cilia D.D., Posvar E.L., and Sedman A.J. J. Clin. Pharm. 32 (1992) 749 abs. #28
50. Nawrocki J.W., Weiss S.R., Davidson M.H., Sprecher D.L., Schwartz S.L., Lupien P.-J., Jones P.H., Haber H.H., and Black D.M. Arterioscler. Thromb. 15 (1995) 678-682
51. Bakker-Arkema R.G., Davidson M.H., Goldstein R.J., Davignon J., Isaacson J.L., Weiss S.R., Keilson L.M., Brown W.V., Miller V.T., Shurzinske L.J., and Black D.M. JAMA 275 (1996) 128-133
52. Jones P., Kafonek S., Laurora I., and Hunninghake D. CURVES Investigators. Am. J. Cardiol. 81 (1998) 582-587
53. Chong P.H., and Seeger J.D. Pharmacotherapy 17 (1997) 1157-1177